13. Percutaneous intervention for aortic valve stenosis

Cerebral embolic protection during TAVI

BHF PROTECT-TAVI
Objective
to report the efficacy of a cerebral embolic protection device (CEP) during TAVI compared to no embolic protection device
Study
multicentre randomised trial in the United Kingdom
Population
patients undergoing TAVI
Endpoints
stroke within 72 hours after TAVI or before discharge
Conclusion
Among patients undergoing TAVI, a cerebral embolic protection device did not decrease the incidence of stroke.
Kharbanda et al. N Engl J Med. 2025 Mar 30.
follow us
Copyright © 2025 Europa Group – All rights reserved.
The content of this site is intended for health care professionals.